{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:57:01Z","timestamp":1791424621723,"version":"4.3.3"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.diagmicrobio.2012.05.024","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T16:08:53Z","timestamp":1341245333000},"page":"62-67","source":"Crossref","is-referenced-by-count":88,"title":["Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase\u2013producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009\u20132010"],"prefix":"10.1016","volume":"74","author":[{"given":"Daryl J.","family":"Hoban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lascols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay E.","family":"Nicolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Badal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Bouchillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Hackel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hawser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0005","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/jac\/dkh218","article-title":"In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics","volume":"53","author":"Alhambra","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/pgm.2010.11.2217","article-title":"Management of complicated urinary tract infections in the era of antimicrobial resistance","volume":"122","author":"Bader","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0015","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1128\/AAC.00353-11","article-title":"Multicenter evaluation of a new DNA microarray for rapid detection of clinically relevant bla genes from beta-lactam-resistant Gram-negative bacteria","volume":"55","author":"Bogaerts","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0020","series-title":"Performance standards for antimicrobial susceptibility testing: 21st informational supplement (M100\u2013S22)","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0732-8893(02)00467-4","article-title":"Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe, Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000)","volume":"45","author":"Gordon","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0035","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/AAC.00265-10","volume":"54","author":"Hawser","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0040","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/AAC.01808-09","article-title":"Susceptibility of Gram-negative pathogens isolated from complicated intra-abdominal infections in the United States 2007\u20132008: results of the SMART study","volume":"54","author":"Hoban","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.diagmicrobio.2009.06.009","article-title":"Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007","volume":"66","author":"Hoban","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.diagmicrobio.2011.03.021","article-title":"Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009\u20132010","volume":"70","author":"Hoban","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jinf.2011.05.015","article-title":"Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region","volume":"63","author":"Hsueh","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0060","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/jac\/dkr240","article-title":"Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009)","volume":"66","author":"Lascols","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0732-8893(01)00254-1","article-title":"Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America)","volume":"40","author":"Mathai","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s15010-011-0132-6","article-title":"Extended-spectrum \u00df-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy","volume":"39","author":"Meier","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0075","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/JCM.00418-06","article-title":"Characterization of a large outbreak of CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development","volume":"44","author":"Mena","year":"2006","journal-title":"J Clin Microbial"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0080","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.48.4.1204-1214.2004","article-title":"Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals","volume":"48","author":"Mulvey","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF01690097","article-title":"Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test","volume":"15","author":"Nuesch-Inderbinen","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0090","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.amjmed.2006.03.013","article-title":"Resistance in Gram-negative bacteria: Enterobacteriaceae","volume":"119","author":"Paterson","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.coph.2007.08.003","article-title":"The continuing challenge of ESBLs","volume":"7","author":"Perez","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0100","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1128\/AAC.42.4.879","article-title":"Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR","volume":"42","author":"Speldooren","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0110","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ijantimicag.2007.07.029","article-title":"Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994\u20132005","volume":"31S","author":"Wagenlehner","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00345-011-0757-1","article-title":"Epidemiology, treatment and prevention of healthcare-associated urinary tract infections","volume":"30","author":"Wagenlehner","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jac\/dki412","article-title":"Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases","volume":"57","author":"Woodford","year":"2006","journal-title":"J Antimcirob Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0125","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2012.05.024_bb0130","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1128\/AAC.00469-10","article-title":"Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008)","volume":"54","author":"Zhanel","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931200209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288931200209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T09:27:21Z","timestamp":1561886841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288931200209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S073288931200209X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.05.024","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}